A Novel Inhibitor of Human La Protein with Anti-HBV Activity Discovered by Structure-Based Virtual Screening and In Vitro Evaluation

BACKGROUND: Over 350 million people worldwide are infected with hepatitis B virus (HBV), a major cause of liver failure and hepatocellular carcinoma. Current therapeutic agents are highly effective, but are also associated with development of viral resistance. Therefore, strategies for identifying o...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Jing, Huang, Zhi-Min, Chen, Ying-Yi, Zhang, Zhao-Hui, Liu, Gao-Lin, Zhang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338670/
https://www.ncbi.nlm.nih.gov/pubmed/22558448
http://dx.doi.org/10.1371/journal.pone.0036363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338670/
https://www.ncbi.nlm.nih.gov/pubmed/22558448
http://dx.doi.org/10.1371/journal.pone.0036363

Ejemplares similares